3-[10-[4-[2-[3-[10-[4-[2-(9H-acridin-10-yl)-4-pyridinyl]-2-pyridinyl]-9H-acridin-2-yl]phenothiazin-10-yl]-4-pyridinyl]-2-pyridinyl]phenothiazin-3-yl]-10-[4-(2-phenoxazin-10-yl-4-pyridinyl)-2-pyridinyl]phenoxazine
C104H66N12O2S2 — CID 146657087
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[10-[4-[2-[3-[10-[4-[2-(9H-acridin-10-yl)-4-pyridinyl]-2-pyridinyl]-9H-acridin-2-yl]phenothiazin-10-yl]-4-pyridinyl]-2-pyridinyl]phenothiazin-3-yl]-10-[4-(2-phenoxazin-10-yl-4-pyridinyl)-2-pyridinyl]phenoxazine
3-[10-[4-[2-[3-[10-[4-[2-(9H-acridin-10-yl)-4-pyridinyl]-2-pyridinyl]-9H-acridin-2-yl]phenothiazin-10-yl]-4-pyridinyl]-2-pyridinyl]phenothiazin-3-yl]-10-[4-(2-phenoxazin-10-yl-4-pyridinyl)-2-pyridinyl]phenoxazine (PubChem CID 146657087) has the molecular formula C104H66N12O2S2 and a molecular weight of 1579.89 g/mol. Its IUPAC name is 3-[10-[4-[2-[3-[10-[4-[2-(9H-acridin-10-yl)-4-pyridinyl]-2-pyridinyl]-9H-acridin-2-yl]phenothiazin-10-yl]-4-pyridinyl]-2-pyridinyl]phenothiazin-3-yl]-10-[4-(2-phenoxazin-10-yl-4-pyridinyl)-2-pyridinyl]phenoxazine.
Molecular Properties
| Compound Name | 3-[10-[4-[2-[3-[10-[4-[2-(9H-acridin-10-yl)-4-pyridinyl]-2-pyridinyl]-9H-acridin-2-yl]phenothiazin-10-yl]-4-pyridinyl]-2-pyridinyl]phenothiazin-3-yl]-10-[4-(2-phenoxazin-10-yl-4-pyridinyl)-2-pyridinyl]phenoxazine |
|---|---|
| PubChem CID | 146657087 |
| Molecular Formula | C104H66N12O2S2 |
| Molecular Weight | 1579.89 g/mol |
| Exact Mass | 1578.49 |
| IUPAC Name | 3-[10-[4-[2-[3-[10-[4-[2-(9H-acridin-10-yl)-4-pyridinyl]-2-pyridinyl]-9H-acridin-2-yl]phenothiazin-10-yl]-4-pyridinyl]-2-pyridinyl]phenothiazin-3-yl]-10-[4-(2-phenoxazin-10-yl-4-pyridinyl)-2-pyridinyl]phenoxazine |
| SMILES | c1ccc2c(c1)Cc1ccccc1N2c1cc(-c2ccnc(N3c4ccccc4Cc4cc(-c5ccc6c(c5)Sc5ccccc5N6c5cc(-c6ccnc(N7c8ccccc8Sc8cc(-c9ccc%10c(c9)Oc9ccccc9N%10c9cc(-c%10ccnc(N%11c%12ccccc%12Oc%12ccccc%12%11)c%10)ccn9)ccc87)c6)ccn5)ccc43)c2)ccn1 |
| InChI | InChI=1S/C104H66N12O2S2/c1-4-20-79-75(17-1)54-76-18-2-5-21-80(76)111(79)99-59-69(41-47-105-99)70-42-48-106-100(60-70)112-81-22-6-3-19-77(81)55-78-53-65(33-37-82(78)112)67-35-39-89-97(57-67)119-95-31-15-10-26-87(95)115(89)103-63-73(45-51-109-103)74-46-52-110-104(64-74)116-88-27-11-16-32-96(88)120-98-58-68(36-40-90(98)116)66-34-38-86-94(56-66)118-93-30-14-9-25-85(93)114(86)102-62-72(44-50-108-102)71-43-49-107-101(61-71)113-83-23-7-12-28-91(83)117-92-29-13-8-24-84(92)113/h1-53,56-64H,54-55H2 |
| InChIKey | HDKKWCYQSAKEBS-UHFFFAOYSA-N |
| XLogP | 28.16 |
| TPSA | 115.24 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 120 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1579.89 |
| LogP ≤ 5 | 28.16 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 16 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146657087 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.